93 results
Page 4 of 5
8-K
EX-99.1
k1n8o65bvbpep7kdu
14 May 20
ENDRA Life Sciences Provides Business Update and Reports First Quarter 2020 Financial Results
4:04pm
PRE 14A
5nen93
17 Apr 20
Preliminary proxy
4:18pm
8-K
EX-99.1
u7lm6w6w3ki xit
13 Apr 20
ENDRA Life Sciences Announces Cash Strategy and Business Update in Response to COVID-19
4:29pm
424B5
eiipp bwpx74
27 Mar 20
Prospectus supplement for primary offering
5:19pm
8-K
EX-99.1
pt6l731 8l4sj
26 Mar 20
ENDRA Life Sciences Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:07pm
8-K
EX-99.1
co9e7ru
10 Mar 20
ENDRA Life Sciences Receives CE Mark for its TAEUS® Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
8:02am
424B3
yit9q9uj7bx9dynp29
28 Jan 20
Prospectus supplement
4:59pm
8-K
EX-99.1
nvn81kjwnt9
15 Jan 20
ENDRA Life Sciences Renews GE Healthcare Collaboration Agreement
10:12am
8-K
EX-99.1
kdtrh1e
11 Dec 19
ENDRA Life Sciences Completes $8.1 Million Private Placement
5:14pm
8-K
EX-99.1
2crobeocq0y33wd
13 Nov 19
ENDRA Life Sciences Provides Business Update and Reports Third Quarter 2019 Financial Results
4:05pm
424B7
d3xma056o y9zw0
16 Sep 19
Prospectus with selling stockholder info
4:10pm